Major immediate-early transcriptional enhancers are genetic control elements that act, through docking with host transcription factors, as a decisive regulatory unit for efficient initiation of the productive virus cycle. Animal models are required for studying the function of enhancers paradigmatically in host organs. Here, we have sought to quantitatively assess the establishment, maintenance, and level of in vivo growth of enhancerless mutants of murine cytomegalovirus in comparison with those of an enhancer-bearing counterpart in models of the immunocompromised or immunologically immature host. Evidence is presented showing that enhancerless viruses are capable of forming restricted foci of infection but fail to grow exponentially.Transcriptional enhancers consist of modules of transcription factor binding sites and mediate gene desilencing and promoter activation in an orientation-independent manner and even from remote sites (4). Whereas the "rheostatic" model, also known as "rate" or "progressive-response" model, proposes that enhancers function by increasing the rate of transcription from a cognate gene, the "binary" model, also known as "on-or-off" or "probability" model, proposes that they function by raising the probability for a cognate gene being in a desilenced state (12). In either case, the result of enhancer action is an increased amount of transcripts. Major immediate-early (MIE) enhancers of herpesviruses enhance the transcription of MIE genes that encode transactivator proteins critically involved in the expression of viral early-phase (E) genes as well as host cell genes. Enhancers are therefore regarded as key regulators for initiating the productive cycle in acute infection as well as in the reactivation from latency. The current knowledge of MIE enhancers of cytomegaloviruses (CMVs), members of the beta subfamily of the herpesviruses, and of the role of the cognate MIE proteins in the viral replication cycle have been comprehensively reviewed recently (3,6,26,27,28,36,42,43). In the specific case of murine CMV (mCMV), the MIE locus consists of a bidirectional gene pair with a promoter-enhancer-enhancer-promoter element (8,11,24,34,40) flanked to the left and to the right by transcription unit ie1-ie3 and gene ie2 that are transcribed in opposite directions and encode the transactivator proteins IE1 and IE3 as well as IE2, respectively (7,21,22,30,31). IE3/M122, corresponding to IE2/UL122 of human CMV (hCMV), has been identified as the essential transactivator for E gene expression (30) and thus for viral replication (1). The two enhancer elements can act independently if engineered in isolation in viruses mCMV-⌬Enh1 or mCMV-⌬Enh2, and act synergistically after infection with wild-type (WT) virus (24).Whereas much is known from infected cell cultures, studies of MIE enhancer function in vivo are restricted to animal models. Accordingly, our knowledge of the in vivo role for MIE enhancers is still incomplete. Notably, orthologous enhancers of different CMV species can replace each other mor...